Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression - Wu K-j, ZengJ; Zhu G-d, ZhangL-l; Zhang, D; Li, L (Acta Pharmacologica Sinica, 2009)
et al.